Claudine Bommer

Windisch, AG 5210, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Cost-effectiveness of pembrolizumab as neoadjuvant therapy and in combination with standard of care (SOC) as adjuvant therapy for stage III-IVA resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC) in Switzerland.

Cost-effectiveness of pembrolizumab as neoadjuvant therapy and in combination with standard of care (SOC) as adjuvant therapy for stage III-IVA resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC) in Switzerland.

Journal: Journal of medical economics

Published: August 07, 2026

Remineralizing potential of the biomimetic P11-4 self-assembling peptide on noncavitated caries lesions: A retrospective cohort study evaluating semistandardized before-and-after radiographs.

Remineralizing potential of the biomimetic P11-4 self-assembling peptide on noncavitated caries lesions: A retrospective cohort study evaluating semistandardized before-and-after radiographs.

Journal: Journal of the American Dental Association (1939)

Published: April 11, 2023

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

Journal: BMC cancer

Published: January 25, 2022

Efficacy and safety of P11-4 for the treatment of periodontal defects in dogs.

Efficacy and safety of P11-4 for the treatment of periodontal defects in dogs.

Journal: Clinical oral investigations

Published: August 10, 2021

Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.

Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: December 20, 2020

Efficacy of P11-4 for the treatment of initial buccal caries: a randomized clinical trial.

Efficacy of P11-4 for the treatment of initial buccal caries: a randomized clinical trial.

Journal: Scientific reports

Published: May 05, 2020

Randomized Clinical Trial investigating Self-Assembling Peptide P11-4 for Treatment of Early Occlusal Caries.

Randomized Clinical Trial investigating Self-Assembling Peptide P11-4 for Treatment of Early Occlusal Caries.

Journal: Scientific reports

Published: September 18, 2019

Hydroxyapatite and Self-Assembling Peptide Matrix for Non-Oxidizing Tooth Whitening.

Hydroxyapatite and Self-Assembling Peptide Matrix for Non-Oxidizing Tooth Whitening.

Journal: The Journal of clinical dentistry

Published: September 14, 2018

Randomised clinical trial investigating self-assembling peptide P11-4 in the treatment of early caries.

Randomised clinical trial investigating self-assembling peptide P11-4 in the treatment of early caries.

Journal: Clinical oral investigations

Published: August 07, 2018

Self-assembling peptide matrix for treatment of dentin hypersensitivity: A randomized controlled clinical trial.

Self-assembling peptide matrix for treatment of dentin hypersensitivity: A randomized controlled clinical trial.

Journal: Journal of periodontology

Published: August 14, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026